Granado et al. reported a downregulation in liver IGF-1 gene expression in another experimental arthritis model [165], while others showed that circulating IGFBPs are increased in arthritis, resulting in reduction in IGF-1 bioavailability [166]. The gene discussed is IGF1; the disease is arthritic joint disease.